Cargando…

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study

INTRODUCTION: Prolactin-secreting pituitary tumors (PRL-omas) are generally benign neoplasia. However, a percentage of cases show aggressive behavior. Prognostic markers may allow for the identification of aggressive cases. In this study, we investigated the prognostic role of galectin-3 and the est...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bima, Chiara, Chiloiro, Sabrina, Giampietro, Antonella, Gessi, Marco, Mattogno, Pier Paolo, Lauretti, Liverana, Anile, Carmelo, Rindi, Guido, Pontecorvi, Alfredo, De Marinis, Laura, Bianchi, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312245/ https://www.ncbi.nlm.nih.gov/pubmed/34322092 http://dx.doi.org/10.3389/fendo.2021.684055

Ejemplares similares

SUN-LB076 Potential Role of Gallium-68-Peptides and Fluorine-18-FDG PET/CT and Ki67 in Patients with Post-Surgical Residual Pituitary Adenoma
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Reappraising the Role of Trans-Sphenoidal Surgery in Prolactin-Secreting Pituitary Tumors
por: Mattogno, Pier Paolo, et al.
Publicado: (2021)

THU055 The Acro-TIME Score: A New Clinical, Pathological And Immune Integrative Approach To Early Identify Acromegaly Patients Resistant To Treatment With First Generation Somatostatin Ligands
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours
por: Iacovazzo, Donato, et al.
Publicado: (2019)

THU050 The Role Of The GH Receptor Polymorphism As Prognostic Factor Of Vertebral Fractures In Acromegaly Patients Resistant To First Generation SSAs And Treated With GH Receptor Antagonist Or Second Generation Somatostatin Ligand
por: Costanza, Flavia, et al.
Publicado: (2023)

Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
por: Bianchi, Antonio, et al.
Publicado: (2023)

Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways
por: Serioli, Simona, et al.
Publicado: (2023)

Gastrointestinal carcinoma first presenting as pituitary mass: recognition of a rare case and multidisciplinary approach for the management of pituitary metastases
por: Costanza, Flavia, et al.
Publicado: (2023)

Colon Cancer Presenting as Pituitary Mass and Hypopituitarism: Recognition and Multidisciplinary Approach of a Rare Case
por: Costanza, Flavia, et al.
Publicado: (2023)

SUN-LB075 Effects of Pegvisomant and Pasireotide LAR on Incidence of Vertebral Fractures in Patients with Acromegaly Resistant to Treatment with First-Line Somatostatin Analogs
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Treatment of giant congenital cysts of the midline in adults: Report of two cases and review of the literature
por: Lauretti, Liverana, et al.
Publicado: (2015)

MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar
por: Chiloiro, Sabrina, et al.
Publicado: (2020)

First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome
por: Chiloiro, Sabrina, et al.
Publicado: (2019)

Reliability of intraoperative visual evoked potentials (iVEPs) in monitoring visual function during endoscopic transsphenoidal surgery
por: Mattogno, Pier Paolo, et al.
Publicado: (2023)

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

Unveiling the Etiopathogenic Spectrum of Hypophysitis: A Narrative Review
por: Menotti, Sara, et al.
Publicado: (2023)

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant
por: Chiloiro, Sabrina, et al.
Publicado: (2021)

Treatment of Clival Chordomas: A 20-Year Experience and Systematic Literature Review
por: Noya, Carolina, et al.
Publicado: (2023)

Integrated Neurosurgical Management of Retroperitoneal Benign Nerve Sheath Tumors
por: Benato, Alberto, et al.
Publicado: (2023)

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly
por: Chiloiro, Sabrina, et al.
Publicado: (2022)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes
por: Bianchi, Antonio, et al.
Publicado: (2013)

Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

THU093 Pituitary Enlargement And Hypopituitarism In Patients Treated With Immune Checkpoint Inhibitors: Two Sides Of The Same Coin?
por: Menotti, Sara, et al.
Publicado: (2023)

Reassessing the Role of Brain Tumor Biopsy in the Era of Advanced Surgical, Molecular, and Imaging Techniques—A Single-Center Experience with Long-Term Follow-Up
por: Di Bonaventura, Rina, et al.
Publicado: (2021)

Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study
por: Gagliardi, Irene, et al.
Publicado: (2021)

Quantitative Anatomical Studies in Neurosurgery: A Systematic and Critical Review of Research Methods
por: Agosti, Edoardo, et al.
Publicado: (2023)

The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
por: Chiloiro, Sabrina, et al.
Publicado: (2023)

Ultra-Early Treatment of Neurosurgical Emergencies with Endoscopic Endonasal Approach: Experience from Three Italian Referral Centers
por: Mattogno, Pier Paolo, et al.
Publicado: (2023)

Neurosurgical Defeats: Critically Ill Patients and the Role of Palliative Care Service
por: D’Alessandris, Quintino Giorgio, et al.
Publicado: (2022)

Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas
por: Xiao, Zhengzheng, et al.
Publicado: (2020)

Treatment of Prolactinoma
por: Inder, Warrick J., et al.
Publicado: (2022)

Nucleoporin 153 regulates estrogen-dependent nuclear translocation of endothelial nitric oxide synthase and estrogen receptor beta in prostate cancer
por: Re, Agnese, et al.
Publicado: (2018)

Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas: Erratum
por: Xiao, Zhengzheng, et al.
Publicado: (2022)

Prolactinomas: evolution after menopause
por: Mallea-Gil, Maria Susana, et al.
Publicado: (2016)

Approach to the Patient With Prolactinoma
por: Auriemma, Renata S, et al.
Publicado: (2023)

A Histopathological Study of Multi-hormone Producing Proliferative Lesions in Estrogen-induced Rat Pituitary Prolactinoma
por: Takekoshi, Susumu, et al.
Publicado: (2014)

Pituitary Hyperplasia, Hormonal Changes and Prolactinoma Development in Males Exposed to Estrogens—An Insight From Translational Studies
por: Šošić-Jurjević, Branka, et al.
Publicado: (2020)

Nerve Torsion as a Pattern of Parsonage–Turner Syndrome: Literature Review and Two Representative Cases
por: Glorioso, Davide, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_43dcabs2nipvnmqvg7ihsn1frj